HSIC Henry Schein, Inc. - Common Stock
NASDAQ · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 5, 2026 10-K/10-Q Ago 4, 2026HSIC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
HSIC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 08 Febbraio 2019 | 51-for-40 | Avanti |
| 15 Settembre 2017 | 2-for-1 | Avanti |
| 01 Marzo 2005 | 2-for-1 | Avanti |
Informazioni su Henry Schein, Inc. - Common Stock Panoramica della società da Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | HSIC | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 24.5media 5 anni ≈21.5 | ≈21.5 | 22.9 | Sopravvalutato | |
| P/S (TTM) | 0.7media 5 anni ≈0.8 | ≈0.8 | 0.5 | Sopravvalutato | |
| P/B (MRQ) | 3.0media 5 anni ≈2.8 | ≈2.8 | · | · | |
| EV / EBITDA | 10.6media 5 anni ≈10.4 | ≈10.4 | · | · | |
| Prezzo / FCF (TTM) | 16.5media 5 anni ≈18.5 | ≈18.5 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 13.4media 5 anni ≈14.8 | ≈14.8 | 14.0 | Valore equo | |
| EV / Revenue (EV / Ricavi) | 0.8media 5 anni ≈0.8 | ≈0.8 | · | · | |
| EV / FCF | 17.8media 5 anni ≈18.9 | ≈18.9 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 4.3 | · | · | · | |
| PEG Ratio | ≈8.1 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | HSIC | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 31.3%media 5 anni ≈30.8% | ≈30.8% | 4.3% | Di prim'ordine | |
| Margine Operativo (TTM) | 5.0%media 5 anni ≈5.5% | ≈5.5% | 1.1% | Di prim'ordine | |
| Margine EBITDA (TTM) | 7.4%media 5 anni ≈7.5% | ≈7.5% | 1.3% | Di prim'ordine | |
| Margine ante imposte (TTM) | 4.1%media 5 anni ≈5.0% | ≈5.0% | 1.0% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 3.0%media 5 anni ≈3.8% | ≈3.8% | 0.63% | Di prim'ordine | |
| ROA (TTM) | 3.6%media 5 anni ≈5.2% | ≈5.2% | 3.1% | Di prim'ordine | |
| ROE (TTM) | 12.2%media 5 anni ≈13.8% | ≈13.8% | -4.6% | Di prim'ordine | |
| ROIC | 12.4%media 5 anni ≈14.2% | ≈14.2% | 12.2% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | HSIC | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.3media 5 anni ≈0.1 | ≈0.1 | 0.3 | In linea | |
| Rapporto corrente (MRQ) | 1.3media 5 anni ≈1.6 | ≈1.6 | 0.9 | Liquidità elevata | |
| Quick Ratio | 0.6media 5 anni ≈0.7 | ≈0.7 | 0.5 | Liquidità elevata | |
| Interest Coverage (Copertura degli interessi) | 4.4media 5 anni ≈12.8 | ≈12.8 | 5.9 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | HSIC | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 4.0%media 5 anni ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 1.4%media 5 anni ≈3.0% | ≈3.0% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 5.4% | · | · | · | |
| EPS YoY | 7.2%media 5 anni ≈6.0% | ≈6.0% | · | · | |
| Net Income YoY (Utile Netto YoY) | 2.1%media 5 anni ≈2.9% | ≈2.9% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | -5.8%media 5 anni ≈-4.6% | ≈-4.6% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | 3.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | -9.6%media 5 anni ≈-7.8% | ≈-7.8% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | -0.30% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | HSIC | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 1.2media 5 anni ≈1.3 | ≈1.3 | 4.5 | Debole | |
| Inventory Turnover (Rotazione delle scorte) | 4.8media 5 anni ≈4.8 | ≈4.8 | 15.7 | Debole | |
| Receivables Turnover (Rotazione dei crediti) | 8.4media 5 anni ≈8.2 | ≈8.2 | 13.1 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$527.4K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 11, 2026 | $1.27 | $1.26 | 0.67% |
| 31 Marzo 2026 | Mag 12, 2026 | $1.32 | $1.24 | 6.3% |
| 31 Dicembre 2025 | $1.34 | $1.33 | 1.1% | |
| 30 Settembre 2025 | $1.38 | $1.30 | 5.8% | |
| 30 Giugno 2025 | $1.10 | $1.22 | -9.5% | |
| 31 Marzo 2025 | $1.15 | $1.13 | 1.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.03 | $27.33 | $28.28 | $26.15 | $24.97 | $23.50 | $20.91 | $19.56 | · | $35.18 | $35.00 | |
| Revenue / Share | $108.32 | $99.18 | $93.66 | $91.81 | $87.47 | $70.56 | $66.90 | $85.89 | · | $141.36 | $126.36 | |
| Cash Flow / Share | $5.85 | $6.64 | $3.80 | $4.37 | $5.00 | $4.18 | $4.38 | $4.45 | · | $7.52 | $6.98 | |
| Cash / Share | $1.35 | $0.98 | $1.32 | $0.89 | $0.86 | · | · | $0.53 | · | $0.79 | $0.87 | |
| EPS (TTM) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | · | $3.10 | $2.85 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | · | 120,199,552 | 121,927,867 | 123,776,073 | · | 126,124,715 | 127,784,380 | 128,720,661 | · | 130,388,353 | 131,365,789 | · | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | · | 121,036,247 | 122,636,948 | 124,848,221 | · | 127,054,934 | 128,646,506 | 129,769,580 | · | 131,442,135 | 133,039,886 | · | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $28.21 | $28.54 | · | $28.35 | $28.26 | $27.08 | · | $27.99 | $27.64 | $28.02 | · | $28.10 | · | · | $26.70 | |
| Revenue / Share | $30.23 | $29.02 | · | $27.59 | $26.42 | $25.37 | · | $24.98 | $24.38 | $24.44 | · | $24.06 | $23.00 | · | $22.37 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $0.30 | · | · | · | $1.52 | · | · | $0.20 | · | · | |
| Cash / Share | $1.40 | $1.21 | · | $1.15 | $1.19 | $1.04 | · | $1.01 | $1.09 | $1.24 | · | $1.28 | · | · | · | |
| EPS (TTM) | $3.43 | $3.31 | · | $3.17 | $3.11 | $3.21 | · | $2.44 | $2.71 | $2.97 | · | $3.38 | $3.52 | · | $4.59 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.60B | $13.38B | · | $12.94B | $12.77B | $12.67B | · | $12.50B | $12.49B | $12.45B | · | $12.69B | $12.53B | · | $12.61B | |
| Net Income TTM | $403M | $395M | · | $391M | $389M | $407M | · | $314M | $352M | $388M | · | $445M | $478M | · | $638M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 24.8 | 21.8 | · | 20.8 | 23.6 | 21.4 | · | 30.0 | 23.7 | 25.4 | · | 22.0 | 23.2 | · | 14.7 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | · | · | · | |
| Earnings Yield | 4.0% | 4.6% | · | 4.8% | 4.2% | 4.7% | · | 3.3% | 4.2% | 3.9% | · | 4.5% | 4.3% | · | 6.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Ricavi | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Margine Lordo % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Margine Operativo % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Utile netto | $398M | $390M | $416M | $538M | $631M |
| EPS Diluito | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
| Metrica | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Rapporto corrente | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
| Metrica | 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $573M | $700M | $353M | $506M | $631M |
Proprietari istituzionali (13F) 600 filer · $11.2B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 64 (-16 vs trimestre precedente) | 60 (+14 vs trimestre precedente) | 173 (-3 vs trimestre precedente) | 220 (+25 vs trimestre precedente) | +9.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1.307.257.713 | 15.652.032 | 11,68% | Azioni |
| VANGUARD GROUP INC | $875.836.080 | 11.588.199 | 7,82% | Azioni |
| FMR LLC | $630.901.802 | 7.553.901 | 5,64% | Azioni |
| BlackRock, Inc. | $586.699.894 | 7.024.663 | 5,24% | Azioni |
| Artisan Partners Limited Partnership | $540.162.844 | 6.467.467 | 4,82% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $530.073.795 | 6.346.669 | 4,73% | Azioni |
| JPMORGAN CHASE & CO | $366.432.667 | 4.342.929 | 3,27% | Azioni |
| STATE STREET CORP | $359.576.652 | 4.305.276 | 3,21% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345.225.076 | 4.133.442 | 3,08% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $288.743.396 | 3.457.175 | 2,58% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $283.495.786 | 3.394.242 | 2,53% | Azioni |
| Southpoint Capital Advisors LP | $275.616.000 | 3.300.000 | 2,46% | Azioni |
| Invesco Ltd. | $263.107.794 | 3.150.237 | 2,35% | Azioni |
| CITADEL ADVISORS LLC | $243.970.523 | 2.921.103 | 2,18% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $227.537.373 | 2.729.030 | 2,03% | Azioni |
| Palestra Capital Management LLC | $204.347.632 | 2.446.691 | 1,83% | Azioni |
| BANK OF MONTREAL /CAN/ | $176.687.394 | 2.115.510 | 1,58% | Azioni |
| MORGAN STANLEY | $175.460.572 | 2.100.819 | 1,57% | Azioni |
| FIDUCIARY MANAGEMENT INC /WI/ | $151.785.323 | 1.817.353 | 1,36% | Azioni |
| Burgundy Asset Management Ltd. | $151.049.204 | 2.170.871 | 1,35% | Azioni |
| LYRICAL ASSET MANAGEMENT LP | $122.553.156 | 1.467.351 | 1,09% | Azioni |
| UBS Group AG | $111.653.127 | 1.336.843 | 1,00% | Azioni |
| Swedbank AB | $109.479.854 | 1.310.822 | 0,98% | Azioni |
| M.D. Sass, LLC | $107.485.396 | 1.286.942 | 0,96% | Azioni |
| SNYDER CAPITAL MANAGEMENT L P | $107.341.992 | 1.285.225 | 0,96% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $107.262.144 | 1.272.537 | 0,96% | Azioni |
| NORGES BANK | $103.383.729 | 1.237.832 | 0,92% | Azioni |
| BANK OF AMERICA CORP /DE/ | $101.266.079 | 1.212.477 | 0,90% | Azioni |
| GOLDMAN SACHS GROUP INC | $98.070.544 | 1.174.216 | 0,88% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86.593.118 | 1.036.795 | 0,77% | Azioni |
| NORTHERN TRUST CORP | $80.548.694 | 964.424 | 0,72% | Azioni |
| NOMURA HOLDINGS INC | $77.065.658 | 922.721 | 0,69% | Azioni |
| PZENA INVESTMENT MANAGEMENT LLC | $71.888.420 | 860.733 | 0,64% | Azioni |
| DME Capital Management, LP | $60.013.296 | 718.550 | 0,54% | Azioni |
| Ananym Capital Management, LP | $57.978.164 | 694.183 | 0,52% | Azioni |
| Ulysses Management LLC | $55.570.700 | 665.358 | 0,50% | Azioni |
| STALEY CAPITAL ADVISERS INC | $55.252.489 | 661.548 | 0,49% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $45.489.502 | 544.654 | 0,41% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $42.948.907 | 514.235 | 0,38% | Azioni |
| Bank of New York Mellon Corp | $42.261.071 | 505.999 | 0,38% | Azioni |
| Nuveen, LLC | $38.262.099 | 458.119 | 0,34% | Azioni |
| DEUTSCHE BANK AG\ | $36.574.075 | 437.908 | 0,33% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35.970.895 | 430.686 | 0,32% | Azioni |
| Clarkston Capital Partners, LLC | $35.168.100 | 421.074 | 0,31% | Azioni |
| LONE PEAK GLOBAL INVESTORS LLC | $33.404.158 | 399.954 | 0,30% | Azioni |
| GAMCO INVESTORS, INC. ET AL | $30.537.668 | 365.633 | 0,27% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $27.342.332 | 370.995 | 0,24% | Azioni |
| PRIVATE MANAGEMENT GROUP INC | $27.285.483 | 326.694 | 0,24% | Azioni |
| FRANKLIN RESOURCES INC | $25.575.244 | 306.217 | 0,23% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $25.194.142 | 301.654 | 0,23% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 depositi | 10 Marzo 2026 | 16,40% | Modifica | · | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 depositi | 08 Agosto 2025 | 13,00% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 52 insider · 25 dirigenti · 22 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 08 Settembre 2026 D | 116.104 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 19 Marzo 2026 S | 86.182 | 0 | 1 | $-98.630 |
| Frederick M. Lowery | CEO | 06 Marzo 2026 A | 95.156 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19 Marzo 2025 S | 62.688 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12 Giugno 2023 S | 68.690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 02 Marzo 2018 A | 62.902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15 Marzo 2016 S | 31.000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 16 Marzo 2026 F | 88.930 | 0 | 0 | $0 |
| James P Breslawski | President | 14 Marzo 2025 D | 200.227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 06 Marzo 2017 A | 9.654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 07 Marzo 2013 M | 48.716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 17 Marzo 2026 G | 112.208 | 0 | 0 | $0 |
| Christine Zayac Sheehy | SVP, Chief Human Res. Officer | 16 Marzo 2026 F | 18.454 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16 Marzo 2026 F | 98.372 | 0 | 2 | $-478.758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14 Marzo 2025 D | 43.191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 06 Settembre 2024 S | 71.833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26 Maggio 2022 S | 95.616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30 Novembre 2018 S | 68.012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 06 Settembre 2017 S | 17.841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12 Maggio 2017 S | 22.943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20 Marzo 2017 M | 23.088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13 Marzo 2017 S | 14.277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 08 Marzo 2017 S | 16.589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 02 Marzo 2016 F | 25.144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17 Marzo 2015 S | 12.343 | 0 | 0 | $0 |
| William K Daniel | Direttore | 12 Giugno 2026 A | 7.641 | 1 | 0 | $691.900 |
| Scott Philip Serota | Direttore | 06 Marzo 2026 A | 10.790 | 0 | 0 | $0 |
| Carole T Faig | Direttore | 06 Marzo 2026 A | 8.025 | 0 | 0 | $0 |
| Anne H. Margulies | Direttore | 06 Marzo 2026 A | 23.153 | 0 | 0 | $0 |
| Mohamad Ali | Direttore | 06 Marzo 2026 A | 15.075 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | Direttore | 06 Marzo 2026 A | 12.520 | 0 | 0 | $0 |
| Robert J. Hombach | Direttore | 06 Marzo 2026 A | 5.421 | 0 | 0 | $0 |
| Bradley T Sheares | Direttore | 06 Marzo 2026 A | 47.623 | 0 | 0 | $0 |
| Philip A Laskawy | Direttore | 06 Marzo 2026 A | 24.538 | 0 | 1 | $-228.544 |
| Carol Raphael | Direttore | 21 Maggio 2025 F | 33.538 | 0 | 0 | $0 |
| Steven Paladino | Direttore | 04 Marzo 2024 A | 138.272 | 0 | 0 | $0 |
| Dianne E Rekow | Direttore | 16 Marzo 2022 A | 18.526 | 0 | 0 | $0 |
| Barry J Alperin | Direttore | 16 Marzo 2022 A | 52.473 | 0 | 0 | $0 |
| Paul Brons | Direttore | 03 Marzo 2021 F | 16.854 | 0 | 0 | $0 |
| Shira Goodman | Direttore | 03 Marzo 2021 A | 5.689 | 0 | 0 | $0 |
| Lawrence S Bacow | Direttore | 06 Marzo 2018 F | 10.115 | 0 | 0 | $0 |
| Donald J Kabat | Direttore | 06 Marzo 2018 F | 10.874 | 0 | 0 | $0 |
| Louis W Sullivan | Direttore | 31 Marzo 2016 A | 14.096 | 0 | 0 | $0 |
| Norman S Matthews | Direttore | 31 Marzo 2016 A | 12.890 | 0 | 0 | $0 |
| Karyn Mashima | Direttore | 10 Marzo 2014 F | 19.269 | 0 | 0 | $0 |
| Irving Shafran | Direttore | 20 Novembre 2003 S | 750.000 | 0 | 0 | $0 |
| Stanley M Bergman | · | 26 Maggio 2026 G | 253.279 | 0 | 5 | $-7.544.687 |
| Kurt P Kuehn | · | 10 Marzo 2026 S | 15.420 | 0 | 1 | $-224.562 |
| Deborah Derby | · | 06 Marzo 2026 A | 15.093 | 0 | 0 | $0 |
| Joseph L Herring | · | 06 Marzo 2026 A | 30.325 | 0 | 0 | $0 |
| Margaret A Hamburg | · | 20 Maggio 2009 M | 0 | 0 | 0 | $0 |
| Pamela Joseph | · | 16 Novembre 2004 S | 98.879 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 86 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 163.520 SH | 02 Ottobre 2026 | Giornaliero |
| GURU · Global X Funds | 1,29% | 9.179 NS | 31 Luglio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,87% | 106.077 NS | 31 Luglio 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,65% | 126.921 SH | 02 Ottobre 2026 | Giornaliero |
| FBCV · FIDELITY COVINGTON TRUST | 0,36% | 7.509 NS | 31 Luglio 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,33% | 18.150 NS | 31 Luglio 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,33% | 12.855 NS | 31 Luglio 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 54.697 SH | 02 Ottobre 2026 | Giornaliero |
| BKMC · BNY Mellon ETF Trust | 0,23% | 17.140 NS | 31 Luglio 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,22% | 364.767 NS | 31 Luglio 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 2.218.557 SH | 02 Ottobre 2026 | Giornaliero |
| FSMD · FIDELITY COVINGTON TRUST | 0,20% | 57.583 NS | 31 Luglio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,19% | 343.006 NS | 31 Luglio 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58.607 SH | 11 Settembre 2026 | Giornaliero |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 41.019 NS | 31 Luglio 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1.416.056 SH | 19 Agosto 2026 | Giornaliero |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 24.666 NS | 31 Luglio 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 3.879 NS | 31 Luglio 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 57.526 SH | 11 Settembre 2026 | Giornaliero |
| NUSC · Nushares ETF Trust | 0,14% | 20.654 NS | 31 Luglio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 46.652 NS | 31 Luglio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293.098 SH | 19 Agosto 2026 | Giornaliero |
| SMMD · iShares Trust | 0,12% | 52.697 SH | 11 Settembre 2026 | Giornaliero |
| IXJ · iShares Trust | 0,11% | 51.636 SH | 11 Settembre 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.230.411 SH | 19 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 0,10% | 1.905 NS | 31 Luglio 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 8.660 SH | 02 Ottobre 2026 | Giornaliero |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7.550 SH | 19 Agosto 2026 | Giornaliero |
| IWS · iShares Trust | 0,08% | 146.411 SH | 10 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,08% | 20.224 NS | 31 Luglio 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 6.020 SH | 11 Settembre 2026 | Giornaliero |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7.214 SH | 19 Agosto 2026 | Giornaliero |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 77.119 SH | 02 Ottobre 2026 | Giornaliero |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6.494 NS | 31 Luglio 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 403.437 SH | 11 Settembre 2026 | Giornaliero |
| DFUV · Dimensional ETF Trust | 0,06% | 98.929 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,05% | 13.423 NS | 31 Luglio 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 125 SH | 11 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,05% | 270.764 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,05% | 2.999 NS | 31 Luglio 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 5.048 SH | 02 Ottobre 2026 | Giornaliero |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 858 NS | 31 Luglio 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 6.000 NS | 31 Luglio 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,04% | 44.360 SH | 02 Ottobre 2026 | Giornaliero |
| DCOR · Dimensional ETF Trust | 0,03% | 13.104 NS | 31 Luglio 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,03% | 22.387 SH | 19 Agosto 2026 | Giornaliero |
| IVE · iShares Trust | 0,03% | 160.669 SH | 11 Settembre 2026 | Giornaliero |
| IUSV · iShares Trust | 0,03% | 83.684 SH | 11 Settembre 2026 | Giornaliero |
| CHRI · Global X Funds | 0,03% | 24 NS | 31 Luglio 2026 | N-PORT |
| DSI · iShares Trust | 0,02% | 14.799 SH | 10 Settembre 2026 | Giornaliero |
| IWD · iShares Trust | 0,02% | 218.760 SH | 11 Settembre 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 59.466 SH | 19 Agosto 2026 | Giornaliero |
| EGLE · Global X Funds | 0,02% | 5 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,02% | 25.929 NS | 31 Luglio 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 132 NS | 31 Luglio 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 3.116 SH | 02 Ottobre 2026 | Giornaliero |
| TOPC · iShares Trust | 0,02% | 59 SH | 10 Settembre 2026 | Giornaliero |
| XCLR · Global X Funds | 0,01% | 6 NS | 31 Luglio 2026 | N-PORT |
| XVV · iShares Trust | 0,01% | 1.104 SH | 11 Settembre 2026 | Giornaliero |
| PTLC · Pacer Funds Trust | 0,01% | 5.070 NS | 31 Luglio 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 1.220.662 SH | 11 Settembre 2026 | Giornaliero |
| XYLD · Global X Funds | 0,01% | 4.788 NS | 31 Luglio 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 576 SH | 02 Ottobre 2026 | Giornaliero |
| DFUS · Dimensional ETF Trust | 0,01% | 30.222 NS | 31 Luglio 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 68.043 SH | 11 Settembre 2026 | Giornaliero |
| XRMI · Global X Funds | 0,01% | 70 NS | 31 Luglio 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 365 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 27.083 SH | 09 Settembre 2026 | Giornaliero |
| IYY · iShares Trust | 0,01% | 4.036 SH | 10 Settembre 2026 | Giornaliero |
| QDPL · Pacer Funds Trust | 0,01% | 2.304 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 123.729 SH | 11 Settembre 2026 | Giornaliero |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 77 SH | 02 Ottobre 2026 | Giornaliero |
| HCMT · Direxion Shares ETF Trust | 0,01% | 674 NS | 31 Luglio 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 2.513.394 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.089.160 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 81.658 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.261 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8.309 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,01% | 22.281 SH | 19 Agosto 2026 | Giornaliero |
| SPXL · Direxion Shares ETF Trust | 0,01% | 7.569 NS | 31 Luglio 2026 | N-PORT |
| XTR · Global X Funds | 0,01% | 4 NS | 31 Luglio 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 99 NS | 31 Luglio 2026 | N-PORT |
| ISCB · iShares Trust | · | 4.208 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 20.757 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 8.316 SH | 11 Settembre 2026 | Giornaliero |
| SMMV · iShares Trust | · | 19.508 SH | 19 Agosto 2026 | Giornaliero |
HSIC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
15 analisti · 2026-09-30Target medio $97.27 +15,8%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | · | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | · |
| ACH | · | · | · | · | · | · |
| MEDS | · | · | · | · | · | · |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.